Results 11 to 20 of about 129,985 (296)

DNA vaccines for bacterial infections [PDF]

open access: yesImmunology & Cell Biology, 1997
DNA vaccines are an exciting development in vaccine technology which may have a special role in preventing viral infections and as ‘theracines’ for cancer. Their use in preventing bacterial infections has, by comparison, been less well documented.
Strugnell, RA   +7 more
openaire   +5 more sources

BactiVac, the Bacterial Vaccines Network [PDF]

open access: yesVaccine
Bacterial vaccines save lives and constitute a major tool to address the challenge of anti-microbial resistance, though, despite their success, there is a relative paucity of such vaccines. Historically there has not been a network that focuses on bacterial vaccines, to promote sharing of approaches and best practices, and provide advocacy.
Calman A, MacLennan   +7 more
openaire   +4 more sources

Recent Developments in Enteric Bacterial Vaccines. [PDF]

open access: yesMicroorganisms, 2021
In this issue, we present promising developments in the field of bacterial enteric vaccines [...
Rijpkema S, Bolgiano B.
europepmc   +2 more sources

The Evolution of Vaccines Development across Salmonella Serovars among Animal Hosts: A Systematic Review [PDF]

open access: yesVaccines
Salmonella is a significant zoonotic foodborne pathogen, and the global spread of multidrug-resistant (MDR) strains poses substantial challenges, necessitating alternatives to antibiotics.
Abubakar Siddique   +9 more
doaj   +2 more sources

Low-Energy Electron Irradiation (LEEI) for the Generation of Inactivated Bacterial Vaccines [PDF]

open access: yes, 2021
S.97-113Vaccines consisting of whole inactivated bacteria (bacterins) are generated by incubation of the pathogen with chemicals. This is a time-consuming procedure which may lead to less immunogenic material, as critical antigenic structures can be ...
Sebastian Ulbert   +11 more
core   +1 more source

Recent Progress in Shigella and Burkholderia pseudomallei Vaccines [PDF]

open access: yes, 2021
Significant advancement has been made in the development of vaccines against bacterial pathogens. However, several roadblocks have been found during the evaluation of vaccines against intracellular bacterial pathogens.
Nittaya Khakhum   +3 more
core   +1 more source

Composing of an oil adjuvant containing BCG as an immunomodulating for rabbit clostridial enterotoxaemia and bloat vaccine [PDF]

open access: yesVeterinary Medical Journal - Giza, 2022
Clostridium perfringens (C. perfringens) is one of the most important pathogen that is widely distributed in all over the world and responsible for many diseases among life stock.
Hamed ElHelw   +4 more
doaj   +1 more source

Chikungunya vaccines: advances in the development and prospects for marketing approval

open access: yesБиопрепараты: Профилактика, диагностика, лечение, 2023
Chikungunya fever is an acute infectious disease caused by the mosquito-borne Chikungunya virus (CHIKV). In the last decades, cases of the disease have been reported in more than 100 countries; therefore, CHIKV presents a global public health problem ...
E. V. Otrasheuskaja   +3 more
doaj   +1 more source

High dissolved oxygen tension triggers outer membrane vesicle formation by Neisseria meningitidis

open access: yesMicrobial Cell Factories, 2018
Background Outer membrane vesicles (OMVs) are nanoparticles released by Gram-negative bacteria and can be used as vaccines. Often, detergents are used to promote release of OMVs and to remove the toxic lipopolysaccharides.
Matthias J. H. Gerritzen   +6 more
doaj   +1 more source

Bacterial outer membrane vesicles and vaccine applications [PDF]

open access: yes, 2014
Vaccines based on outer membrane vesicles (OMV) were developed more than 20 years ago against Neisseria meningitidis serogroup B. These nano-sized structures exhibit remarkable potential for immunomodulation of immune responses and delivery of “self ...
Jose Luis Perez   +30 more
core   +1 more source

Home - About - Disclaimer - Privacy